Appendix E: Management of Women with Bleeding Irregularities While Using Contraception*

Pages in this Report
  1. Table of Contents
  2. Summary
  3. Introduction
  4. How To Be Reasonably Certain that a Woman Is Not Pregnant
  5. Intrauterine Contraception
  6. Implants
  7. Injectables
  8. Combined Hormonal Contraceptives
  9. Progestin-Only Pills
  10. Standard Days Method
  11. Emergency Contraception
  12. Female Sterilization
  13. Male Sterilization
  14. When Women Can Stop Using Contraceptives
  15. Conclusion
  16. References
  17. Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
  18. When To Start Using Specific Contraceptive Methods
  19. Examinations and Tests Needed Before Initiation of Contraceptive Methods
  20. Routine Follow-Up After Contraceptive Initiation
  21. Management of Women with Bleeding Irregularities While Using Contraception
  22. Management of Intrauterine Devices When Users are Found To Have Pelvic Inflammatory Disease
  23. Participants
Related Pages

 

Abbreviations: CHC = combined hormonal contraceptive; COC = combined oral contraceptive; Cu-IUD = copper-containing intrauterine device; DMPA = depot medroxyprogesterone acetate; LNG-IUD = levonorgestrel-releasing intrauterine device; NSAIDs = nonsteroidal antiinflammatory drugs.

*If clinically warranted, evaluate for underlying condition. Treat the condition or refer for care. Heavy or prolonged bleeding, either unscheduled or menstrual, is uncommon among LNG-IUD users and implant users.

Page last reviewed: February 1, 2017
Content source: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion